BRiEf COmmuNiCATiONs ARisiNg
Epithelial-to-mesenchymal transition (EMT) is a cellular program that operates in the context of embryogenesis, wound healing and carcinoma pathogenesis to drive epithelial cells towards a mesenchymal state. During carcinoma progression, EMT enables the cells forming these tumours to acquire the traits of highly malignant cells, notably motility, invasiveness and an ability to disseminate to form distant metastases. Indeed, a number of published reports have associated EMT with a variety of malignant carcinoma cells. Recently, however, Zheng et al. 1 reported that in genetically engineered mouse models of pancreatic adenocarcinoma development, carcinoma cells could metastasize without activating EMT programs. Their conclusions, if sustained by the evidence presented, would prompt a major change in how we conceptualize malignant progression and metastasis of carcinoma cells, including the neoplastic cells in human carcinomas.
To assess the role of EMT in metastasis, Zheng et al. 1 deleted Snai1 or Twist1-two important EMT-associated transcription factors. Despite this deletion, neither conditional knockout exhibited a decrease in the rate of metastasis of pancreatic carcinoma cells. The authors concluded that EMT is dispensable for metastasis based on their claim that deletion of either Snai1 or Twist1 significantly attenuates EMT. On the basis of the caveats we highlight below, we believe that evidence that EMT programs were eliminated is incomplete in the report by Zheng et al. 1 Zheng et al. 1 used a lineage-traced mouse model of pancreatic cancer similar to the model previously reported by Rhim et al. 2 , in which all carcinoma cells are unambiguously marked by yellow fluorescent protein (YFP). They show that tumours in animals with a conditional Twist1 knockout exhibited a significant reduction in the percentage of YFP + cells that co-expressed the mesenchymal marker α -smooth muscle actin (α SMA) relative to tumours with an intact Twist1 locus. At face value, this would seem to be a good indicator that the EMT was indeed suppressed in the pancreatic carcinoma cells. However, unlike several other mesenchymal markers, our data indicate that α SMA expression is rarely induced upon activation of EMT in this mouse tumour model (Fig. 1) .
Although the authors 1 also stained for other EMT markers, including Zeb1, Zeb2, Slug, and Sox4, these stains were done without marking the tumour cells with a lineage-specific tracer. Consequently, one cannot discern whether any particular detected marker was present in a carcinoma cell or in a non-neoplastic stromal cell that was recruited to a pancreatic tumour; for this reason, the effect on EMT of the Snai1 and the Twist1 deletion remains undefined. Indeed, there is abundant evidence that the tumours described in Zheng et al. 1 continued to exhibit EMT phenotypes despite loss of either Snai1 or Twist1. For example, poorly differentiated regions of these tumours-histologically defined zones reflecting EMT-were undiminished upon Snai1 or Twist1 deletion. Moreover, the tumour cells of the primary tumours still expressed considerable levels of the other EMT transcription factors, as shown for the Zeb1, Sox4 and Slug EMT transcription factors following deletion of either Snai1 or Twist1.
Likewise, in carcinoma cells isolated from both of these conditional knockout primary tumours, quantitative PCR demonstrated that expression of Zeb1 and Slug mRNAs was reduced by approximately twofold, a decrease that is plausibly inconsequential functionally; importantly, expression of the mesenchymal markers vimentin and N-cadherin was only slightly downregulated and the downregulation was not statistically significant. It has been well-established that EMT is not a single, stereotypical program but instead has multiple manifestations, many of which endow epithelial cells-both normal and neoplastic-with a variety of traits normally expressed by mesenchymal cells 3 . Importantly, EMT is achieved through the action of multiple context-dependent signals and EMT-related transcription factors; furthermore, cells activating an EMT program may lose their epithelial properties and acquire invasive properties by progressing only part way through an EMT program ('partial EMT'). Thus, EMT programs could have persisted in the pancreatic carcinoma cells studied by Zheng et al. 1 Thus, while the results of Zheng et al. 1 are interesting and may speak to redundancy within the transcriptional network that defines and orchestrates EMT in pancreatic carcinomas, we believe that the authors' genetic manipulations failed to suppress expression of versions of the EMT program and therefore to completely suppress activation of EMT. Hence, in our view, the conclusion that EMT is not required for metastatic dissemination would require further evidence. Accordingly, we continue to subscribe to the notion that pancreatic carcinoma cells utilize an EMT program or programs during metastatic dissemination. 
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